Filing Details

Accession Number:
0001179110-15-011898
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-07 16:45:57
Reporting Period:
2015-08-06
Filing Date:
2015-08-07
Accepted Time:
2015-08-07 16:45:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166776 Paul Thomas 22 Cherry Hill Dr
Danvers MA 01923
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2015-08-06 7,500 $7.92 28,313 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2015-08-06 5,900 $93.60 22,413 No 4 S Direct
Common Stock, $.01 Par Value Disposition 2015-08-06 1,600 $94.22 20,813 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2015-08-06 7,500 $0.00 0 $7.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2011-01-29 2020-01-29 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option (right to buy) $18.94 2014-01-29 2020-05-26 0 10,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-05-26 0 10,000 Direct
Footnotes
  1. Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  2. These options become exerciseable in annual increments: 1/3 on each of January 29, 2011, January 29, 2012 and January 29, 2013.
  3. These options become exerciseable as following: 50% on the date shown in Table II, Column 6, and 50% on January 29, 2015.
  4. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $93.0000 and $93.9800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  5. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $94.0100 and $94.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.